Glenmark Pharmaceuticals (₹395.4): Sell bl-premium-article-image

Akhil NallamuthuBL Research Bureau Updated - June 09, 2022 at 06:15 AM.

The stock of Glenmark Pharmaceuticals has been on a downtrend since July 2021 after facing resistance around ₹690.

That said, it was largely oscillating within the range of ₹385-410 for the past one month. However, it broke below the lower end of the range on Tuesday. Although it rallied on Wednesday, it is most likely to be a corrective one and there could be fresh selloffs in the upcoming sessions.

Since it has pulled back on Wednesday following a breakdown, it gives us an opportunity to consider this stock for intra-day short positions in Thursday's session. Traders can go short on the stock at the current price level of around ₹395. Place stop-loss at ₹405 as a rally beyond ₹400 might not happen, at least on Thursday. Exit the shorts when the price falls to ₹375. Those who wish to carry the shorts can do so for a target of ₹340 in a month or so. But if the stock opens above ₹400 on Thursday, refrain from trading.

(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)

Published on June 9, 2022 00:45

This is a Premium article available exclusively to our subscribers.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

TheHindu Businessline operates by its editorial values to provide you quality journalism.

This is your last free article.